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Abstract: Gyroxin, a thrombin-like enzyme isolated from Crotalus durissus terrificus venom and capable of 
converting fibrinogen into fibrin, presents coagulant and neurotoxic activities. The aim of the present study 
was to evaluate such coagulant and toxic properties. Gyroxin was isolated using only two chromatographic 
steps – namely gel filtration (Sephadex G-75) and affinity (Benzamidine Sepharose 6B) – resulting in a sample 
of high purity, as evaluated by RP-HPLC C2/C18 and electrophoretic analysis that showed a molecular 
mass of 30 kDa. Gyroxin hydrolyzed specific chromogenic substrates, which caused it to be classified as a 
serine proteinase and thrombin-like enzyme. It was stable from pH 5.5 to 8.5 and inhibited by Mn2+, Cu2+, 
PMSF and benzamidine. Human plasma coagulation was more efficient at pH 6.0. An in vivo toxicity test 
showed that only behavioral alterations occurred, with no barrel rotation. Gyroxin was not able to block 
neuromuscular contraction in vitro, which suggests that its action, at the studied concentrations, has no 
effect on the peripheral nervous system.
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INTRODUCTION
The active components of snake venom 
can be used as important tools to elucidate 
many pharmacological mechanisms including 
neuromuscular junction transmission, blood 
coagulation cascade, fibrinolysis, complement 
system and inflammatory processes (1, 2). Among 
snake venom proteins, metalloproteinases and 
serine proteinases are responsible for blood 
hemodynamic alterations (clot formation and 
clot dissolution) (3, 4).
Serine proteinases are abundant, especially 
in Viperidae venoms, in which they account for 
about 20% of the total protein content (5, 6). These 
enzymes display in vitro coagulant activity and 
are often referred to as thrombin-like enzymes, 
since their function resembles that of the best 
known of human and animal thrombin, namely 
the ability to cleave fibrinogen into fibrin, leading 
to clot formation (7, 6). Snake venom thrombin-
like enzymes (SVTLEs) can act by cleaving 
both chains of fibrinogen, Aa and Bb, releasing 
fibrinopeptides A (FpA) and/or fibrinopeptides B 
(FpB) (2, 5). 
Gyroxin belongs to the thrombin-like group 
and was isolated from the venom of Crotalus 
durissus terrificus by Raw et al. (8) in 1986 using 
three chromatographic steps of purification 
(ammonium sulfate precipitation, Sephadex 
G-75 and Sepharose-1,4 butanediol-diglycyl-p-
aminobenzamidine). The electrophoretic analysis 
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showed a mass of 34 kDa and an optimum pH for 
human blood coagulation of 8.0 (8). 
Besides acting on coagulation, gyroxin 
presents an outstanding neurotoxic activity 
causing a syndrome called “barrel rotation”. 
This syndrome was observed for the first time 
by Barrio (9) in 1961, who described the effects 
of gyroxin isolated from the Crotalus durissus 
terrificus venom.
This enzyme can be an interesting molecular 
model for the development of drugs or 
therapeutic agents (10-12), mainly due to its 
resistance to physiological proteinase inhibitors 
(2, 3). In the present study, we described a 
two-step isolation and biochemical/biological 
characterization of gyroxin from Crotalus 
durissus terrificus venom. 
MATERIALS AND METHODS
Materials
Crotalus durissus terrificus snake venom, 
vacuum dried and stored at 4°C, was obtained 
from specimens kept in the serpentarium of the 
Center for the Studies of Venoms and Venomous 
Animals (CEVAP), São Paulo state, Brazil. 
Sephadex G-75, Benzamidine Sepharose 6B, C2/
C18 column for RP/HPLC and molecular weight 
markers were purchased from Amersham Life 
Science Inc (Sweden). The H-D-Phe-pipecolyl-
Arg-pNA.2HCl (S-2238) and H-D-Ile-Pro-
Arg-pNA.2HCl (S-2288) substrates came from 
Chromogenix (Italy). All other reagents used for 
chemical and biological characterization were 
of analytical grade and purchased from Sigma 
Chemical Co (USA). The plasma was obtained 
from healthy donors, aged between 18 and 42 
years, kindly provided by the Botucatu Medical 
School Blood Bank, São Paulo, Brazil.
Animals
Swiss mice were obtained from the Botucatu 
Medical School Animal Facility (São Paulo 
state, Brazil) and maintained under standard 
conditions (temperature 22 ± 1°C, relative 
humidity 60 ± 5%, 12-hour light/dark cycle) with 
food and water ad libitum. The experimentation 
protocol was approved by the Ethics Committee 
on Animal Experimentation of the Botucatu 
Medical School, São Paulo State University, São 
Paulo state, Brazil (protocol number 657-2008) 
and is in agreement with the ethical principles of 
animal experimentation adopted by the Brazilian 
Society of Science for Laboratory Animals.
Gyroxin Isolation
Crotalus durissus terrificus crude venom (1 
g) was applied to a Sephadex G-75 column (110 
x 4.0 cm), previously equilibrated with 0.05 M 
ammonium formiate, pH 3.5. Elution was carried 
out using the same buffer at a flow rate of 30 mL/
hour, collecting 1 mL/tube. The fraction showing 
clotting activity was applied to a Benzamidine 
Sepharose 6B column (8.5 x 2.5 cm) previously 
equilibrated with 0.05 M Tris-HCl buffer, pH 
7.4. Elution started at room temperature, with 
30 mL of the same buffer containing 0.5 M NaCl 
followed by 20 mL of glicine (0.02 M, pH 3.2), and 
it was ended by adding 400 µL Tris-HCl (1.0 M, 
pH 9.0). The flow rate was 30 mL/hour, collecting 
3 mL/tube.
The active fraction was concentrated by 
ultrafiltration in an Amicon YM10 System 
(Millipore, USA) and then applied to reverse 
phase HPLC using a C2/C18 column of 2.0 x 25 
cm (Shimadzu, Japan), which was equilibrated 
with solvent A (0.1% trifluoroacetic acid) and 
eluted with a concentration gradient of solvent B 
(70% acetonitrile) from 0 to 100% at a flow rate of 
1 mL/minute at room temperature. 
Biochemical Characterization
Determination of relative molecular mass (Mr)
The 13.5% SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) was performed 
according to Laemmli (13). Samples were 
heated at 70°C for five minutes and then 
run under reducing conditions (SDS + 10% 
β-mercaptoethanol). The gel was stained with 
Coomassie brilliant blue R-250 (Pharmacia 
Biotech, USA). Mr was estimated by interpolation 
from a linear logarithmic plot of relative molecular 
mass versus distance of migration. The molecular 
mass markers used were: bovine serum albumin 
(66 kDa), ovalbumin (45 kDa), glyceraldehyde-
3-phosphate dehydrogenase (36 kDa), carbonic 
anhydrase (29 kDa), trypsinogen (24 kDa), 
trypsin inhibitor (20.1 kDa) and α-lactalbumin 
(14.4 kDa) (Amersham Biosciences).
Isoelectric focusing
The pI of the isolated protein was determined 
according to the method previously described by 
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Vesterberg (14) with some modifications. A 7% 
polyacrylamide gel with ampholine at pH 3.0 to 
10.0 was used in a preliminary run for 30 minutes 
at 500 V. After this, a 1-mg/mL sample of enzyme 
(10 µL) in aqueous solution with 10% glycerol 
was poured into the gel. Isoelectric focusing 
markers (β-lactaglobulin, carbonic anhydrase 
and trypsinogen) were run parallel to the sample 
for five hours at 1500 V. Two strips were used 
to connect the gel and the platinum electrodes, 
with cathode in 1M NaOH and anode in 1 M 
phosphoric acid. The experiments were carried 
out at 4°C and the pI bands were detected by 
silver staining (Pharmacia Biotech, USA).
N-terminal sequencing
The N-terminal sequence of enzyme was 
determined using Shimadzu PPSQ-23A 
(Japan) automatic protein sequencer based on 
Edman degradation (15), using a solution with 
approximately 1 mg/mL of the purified enzyme. 
The sequence and homology of the amino acids 
were analyzed by alignment using the BLAST 
program (blast.ncbi.nlm.nih.gov) (16) and 
compared with four other sequences of serine 
proteinases present in the National Center for 
Biotechnology Information (NCBI): gyroxin 
analog from Lachesis muta muta; ancrod from 
Agkistrodon rhodostoma; crotalase from Crotalus 
adamanteus and gyroxin from Crotalus durissus 
terrificus.
Enzymatic Characterization
Hydrolytic activity upon synthetic substrates
The ability of gyroxin to hydrolyze chromogenic 
substrates S-2238 (for thrombin-like enzymes) 
and S-2288 (for serine proteinase) (0.5 mM, 
final concentration) was tested in a Thermomax 
Microplate reader (Molecular Devides, USA) 
monitored at 450 nm for 20 minutes at 37°C. 
When indicated, divalent ions (Ca2+, Ba2+, Mn2+ 
and Cu2+), inhibitors (20 mM EDTA and 10 
mM 1,10-phenanthroline which are specific to 
metalloproteases or 20 mM PMSF and 150 mM 
benzamidine specific to serine proteinases) as 
well as buffers at different pH values (3.5, 4.5, 
5.5, 6.8, 7.5, 8.5, 11 and 13) were preincubated 
for 20 minutes at 37°C with gyroxin, and then 
the enzymatic reaction was assayed with a 
chromogenic substrate, S-2238 (17). 
Clotting activity upon human plasma
The clotting time was determined by mixing 
100 μL of the samples (in MilliQ water, pH 4.0, 
6.0 and 7.4) with 200 µL of citrated human plasma 
at 37°C. Different amounts of the enzyme (3.0 to 
25.0 µg) were also assayed in order to determine 
the minimum coagulant dose (MCD), which 
indicates the smallest amount of enzyme able 
to completely coagulate citrated human plasma 
in 60 seconds (18). Each dose was assayed in 
triplicate. The maximum period for observation 
of clot formations was five minutes.
Biological Activities
In vivo toxicity test
The in vivo test was performed using Swiss 
mice, injected with test samples at 0.1 to 0.6 μg/g 
body weight by intraperitoneal injection and 
observed for 60 minutes. Barrel rotation or other 
symptoms should appear spontaneously in this 
period. A typical barrel rotation consisted of at 
least one full rotation over the long axis of the 
body, performed in one second or less (19).
Neuromuscular blocking activity (in vitro 
toxicity test)
Mice were euthanized by exsanguination after 
choral hydrate anesthesia. Phrenic-diaphragm 
(PD) preparation was removed according to 
Bülbring (20), and mounted vertically in a 
conventional isolated organ-bath chamber 
containing 10 mL of physiological solution of 
the following composition (mmol/L): NaCl, 
135; KCl, 5; MgCl2, 1; CaCl2, 2; NaHCO3, 15; 
Na2HPO4, 1; glucose, 11. This solution was 
bubbled with carbogen (95% O2 and 5% CO2). 
The preparation was attached to an isometric 
force transducer (Grass, FT03) to record the 
twitch tension. The transducer signal output 
was amplified and recorded on a computer via 
a transducer signal conditioner (Gould, 13-
6615-50) with an AcquireLab Data Acquisition 
System (Gould, USA). The resting tension 
was 5 g. Indirect contractions were evoked by 
supramaximal pulses (0.2 Hz, 0.5 ms) delivered 
from an electronic stimulator (Grass-S88K) 
and applied to the phrenic nerve by means of a 
suction electrode. The preparation was allowed 
to stabilize for 45 minutes before the addition of 
enzyme (25 and 40 µg/mL). Control experiments 
were performed in the absence of enzyme.
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Table 1. Comparison of the N-terminal amino acid sequence of gyroxin with other snake venom serine 
proteinases
Enzyme Snake species N-terminal amino acid sequence
NCBI 
access 
code
References
Gyroxin
Crotalus 
durissus 
terrificus
VIGGDECNINEHRFLVALYE Present study
Gyroxin analog Lachesis muta muta VIGGDECNINEHRFLVALYD gi: 464885 21
Ancrod Agkistrodon rhodostoma VIGGDECNINEHRFLVALYD gi: 113827 22
Crotalase Crotalus adamanteus VIGGDECNINEHRFLVALYD gi: 250562 23
Gyroxin
Crotalus 
durissus 
terrificus
VIGGDECNINEHRFLVALYE gi: 61741494 24
Statistical Analysis
All data are presented as means ± SE. Data were 
analyzed using analysis of variance (ANOVA) to 
evaluate the statistical differences among groups. 
In all cases, the significance level was considered 
to be p < 0.05. Minimal coagulant doses (MCD) 
were calculated using potential regression analysis 
(y = A . x–B). 
RESULTS
Isolation and Biochemical Characterization
Fractionation by Sephadex produced four 
major protein peaks (Figure 1 – A), denominated 
S1 to S4. Only S2 showed clotting activity. 
After lyophilization, S2 was submitted to 
another chromatographic step on Benzamidine 
Sepharose 6B which yielded three new fractions, 
named BS1 to BS3 (Figure 1 – B). Fraction BS3 
(gyroxin) showed in vitro coagulant activity 
upon human plasma and was analyzed by 
reverse-phase HPLC chromatography (Figure 
1 – C).
This protein fraction consisted of an apparent 
single polypeptide chain presenting a molecular 
mass of approximately 30 kDa in SDS-PAGE 
under reducing conditions (Figure 1 – D) and pI 
~ 5.5 (Figure 1 – E).
The sequence of the first 20 amino acid 
residues from the N-terminal region of gyroxin 
showed high similarity with other thrombin-like 
serine proteinases and a 100% similarity with 
the gyroxin of Crotalus durissus terrificus stored 
in the data bank (Table 1).
From these results, the serine proteinase 
isolated and purified from Crotalus durissus 
terrificus venom was identified as gyroxin.
Functional Characterization
Gyroxin was able to hydrolyze both S-2238 
and S-2288 chromogenic substrates in a 
concentration-dependent manner (Figure 
2 – A). Both substrates are regularly used for 
thrombin-like or serine proteases, respectively. 
Gyroxin’s enzymatic activity upon S-2238 was 
inhibited by PMSF and benzamidine, while 
EDTA or 1,10-phenanthroline did not abolish 
its activity (Figure 2 – B). Moreover, the activity 
of gyroxin was higher at pH values from 7.5 to 
8.5 (Figure 2 – C). At pH values of 3.5, 4.5 and 
13 no activity on S-2238 was detected (Figure 2 
– C). We also assayed the influence of different 
divalent ions on hydrolysis of S-2238 induced 
by gyroxin. As shown in Figure 2 – D, no activity 
was observed in the presece of Mn2+ or Cu2+, but 
addition of Ca2+ fully restored gyroxin’s activity 
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Figure 1. Sequential purification steps of gyroxin. (A) Crotalus durissus terrificus venom (1 g) on Sephadex 
G-75, in 0.05 M ammonium formate buffer, pH 3.5. Fractions of 10  mL/tube were collected at a flow rate 
of 30 mL/hour. (B) The active coagulant fraction, denominated S2 (100 mg), was rechromatographed on a 
Benzamidine Sepharose 6B column (8.5 x 2.5cm) previously equilibrated with 0.05 M Tris-HCl, pH 7.4 plus 
NaCl 0.5 M (solvent A) at room temperature and then eluted with 20 mL of glycine 0.02 M, pH 3.2 (solvent 
B), ending up with 400 µL of Tris-HCl 1.0 M pH 9.0. (C) Analysis of BS3 (gyroxin) by RP-HPLC using a C2/C18 
column of 4.6 x 100 mm (Shimadzu, Japan), equilibrated with solvent A (0.1% trifluoroacetic acid and 5% 
acetonitrile) and eluted with a concentration gradient of solvent B (60% acetonitrile, 0.1% trifluoroacetic 
acid) from 0 to 100% at a flow rate of 1 mL/minute at room temperature. (D) SDSPAGE (13.5%) of gyroxin. 
Lanes: (1) molecular mass markers, (2 and 3) purified gyroxin. (E) pI determination for gyroxin, pI~ 5.5.
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Figure 2. Gyroxin activity upon synthetic substrates (0.5 mM). (A) Concentration-dependent hydrolysis of 
S-2238 and S-2288. (B) Effect of inhibitors; groups: no inhibitor (column 1); 20 mM EDTA (column 2); 10 mM 
1,10-phenanthroline (column 3); 20 mM PMSF (column 4) or 150 mM benzamidine (column 5). (C) Effect 
of pH (3.5, 4.5, 5.5, 6.8, 7.5, 8.5, 11 and 13) and (D) effect of 10 mM divalent metals: without adding any ion 
(column 1); Ca2+ (column 2); Ba2+ (column 3); Mn2+ (column 4); Cu2+ (column 5) on the hydrolysis of S-2238 
induced by 20 µg/mL gyroxin after a 10-minute reaction at 37°C. Data are expressed as means ± SD of two 
individual experiments (n = 3). Asterisks (*) represent significance (p < 0.05) compared to column 1.
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on that chromogenic substrate. In parallel, the 
addition of Ba2+ was also unable to restore such 
gyroxin activity (Figure 2 – D).
Gyroxin showed a high clotting activity upon 
human plasma with MCD = 0.037 µg/µL (pH 
4.0), 0.015 µg/µL (pH 6.0), and 0.021 µg/µL (pH 
7.4).
The barrel rotation was not observed but 
other behavioral effects were registered such 
as periods of hyperexcitation and running 
followed by tachypnea, immobility, stretching 
of posterior limbs and grooming behavior. 
The animals recovered in one hour after the 
injection and after 24 hours the picture was 
asymptomatic. Gyroxin did not induce the 
blockade of twitch evoked indirectly in mouse 
phrenic-diaphragm preparation as illustrated 
in Figure 3.
DISCUSSION
The most employed techniques for the isolation 
and purification of thrombin-like enzymes 
have been gel filtration followed by affinity 
chromatographic steps with few modifications, 
in the pursuit of ideal conditions for better 
resolution and yield (25, 26).
To isolate the gyroxin by gel filtration, the 
Sephadex G-75 column at a low pH (ammonium 
formiate pH 3.5) was used which, besides 
maintaining the integrity of fractions and thus 
preventing their degradation, promoted a better 
separation resulting in four distinct peaks, in 
agreement with other authors who also showed 
four peaks using the same process (27, 28). Peak 
II showed coagulant and esterasic activities, 
and was submitted to affinity chromatography 
Figure 3. Effects of gyroxin on indirectly evoked twitches in mouse phrenic-diaphragm preparations. 
The ordinate represents the amplitude percentage (%) of twitches relative to the initial amplitude. The 
abscissa indicates the time (minutes) after the addition of gyroxin to the organ bath. The results indicate 
no significant differences produced by gyroxin at 25 µg/mL or gyroxin at 40 µg/mL in relation to control (p 
≤ 0.05).
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on Benzamidine Sepharose 6B. Using elution at 
different pHs (buffer 2 pH 7.4 and buffer 3 pH 
3.2), this step resulted in three distinct peaks and 
the enzyme of interest was located in the third 
and lowest peak after elution with glycine. 
Differing from these results, Raw et al. (8) 
showed only two peaks resulting from an affinity 
chromatography on Sepharose-1,4 butanediol-
diglycyl-p-aminobenzamidine, and the second 
and lower peak, after elution with benzamidine, 
demonstrated thrombin-like activity. Alexander 
et al. (25), in 1988, using affinity chromatography 
on Benzamidine Sepharose 6B found two peaks 
after elution with benzamidine, verifying that only 
the second and lower peak showed thrombin-like 
coagulant activity, characteristic of gyroxin. 
The molecular mass of Crotalus durissus 
terrificus gyroxin has been estimated by several 
authors as being between 29 and 36 kDa (25, 
29). According to electrophoretic analysis in 
denaturing conditions, the gyroxin isolated in 
this study revealed a molecular mass of ~30 kDa. 
This result corroborates recent studies realized 
by De Oliveira et al. (30). The pI value of the 
purified serine proteinase was 5.5 indicating an 
acidic characteristic to the protein, agreeing with 
studies that indicate a variable pI between 4.6 and 
6.6 for serine proteinases (31).
Since the gyroxin was highly enriched, as 
determined by SDS-PAGE, further assessment of 
gyroxin purity was conducted by reverse-phase 
HPLC using a C2/C18 column that showed a 
single peak.
N-terminal sequence has been utilized to show 
similarity and identity with protein isolated by 
other authors and already characterized. In this 
study, the isolated and purified protein exhibited 
almost 100% similarity to other thrombin-like 
enzymes previously characterized by analysis 
of the first 20 amino acid residues, suggesting a 
common molecular ancestry. This high homology 
among the coagulant enzymes is confirmed by 
the presence of valine (V) as the first N-terminal 
residue, a common feature of most SVTLEs (32), 
enabling the classification of the isolated serine 
proteinase as gyroxin.
Gyroxin catalyzed the hydrolysis of the 
chromogenic substrates S-2238 and S-2288, thus 
demonstrating itself to be a serine proteinase that 
belongs to the thrombin-like enzyme group. These 
peptides H-D-Phe-pipecolyl-Arg-pNA.2HCl (S-
2238) and H-D-Ile-pro-Arg-pNA.2HCl (S-2288) 
are the substrates most susceptible to hydrolysis 
by gyroxin, since their active centers have an 
anionic nature that requires high specificity 
and preference for amino acid residues such as 
arginine (33).
Benzamidine efficiently inhibited the activity 
of the enzyme upon S-2238 substrate, in contrast 
to a partial inhibition when PMSF was used 
because it is classified as a serine proteinase 
inhibitor. The PMFS has the ability to bind 
irreversibly to the serine residue at the catalytic 
site leading to the inactivation of the protein. 
These data were confirmed by studies carried out 
with a thrombin-like enzyme, known as BpSP-I, 
isolated from the venom of Bothrops pauloensis 
(34).
Gyroxin showed a high stability in maintaining 
normal activity upon S-2238 substrate when 
incubated at different pHs (7.5 to 8.5); however, 
at low (3.5 to 4.5) and high (over 13.0) pHs, the 
enzyme lost its activity. This feature was similar 
to that of calobin II, isolated from the venom 
of Agkistrodon caliginosus, which presented an 
optimum pH of 8.0 but was drastically affected at 
pHs below 6.0 and over 10.0 (35).
In the presence of Ca2+, the gyroxin activity was 
stable. It was also observed that in the presence of 
Mn2+ and Cu2+, the activity was inhibited. Based 
on these data, it was suggested that these ions 
provoke some direct or indirect conformational 
changes at the protein catalytic site that decrease 
its efficiency (36). 
In contrast, the serine proteinases present in 
vitro coagulant activity upon human plasma, a 
characteristic of gyroxin (8, 25). In the present 
study, gyroxin showed a high level of coagulant 
activity with a minimal coagulant dose of 0.037 
to 0.015 µg/µL when compared with data of 
De Oliveira et al. (30), who found a minimal 
coagulant dose of 1.5 µg/µL. It was stable across 
a large pH range, while its action upon human 
plasma was observed between 6.0 and 7.4, similar 
to thrombin’s optimum pH (7.3).
The in vivo toxicity evaluation of gyroxin 
revealed some behavioral effects on mice 
including: initial hyperexcitation and running 
followed by tachypnea, immobility, stretching 
of posterior limbs and grooming behavior, 
corroborating previous results in the literature 
(37). However, Camillo et al. (29) observed the 
barrel rotation, described by Barrio (9), when the 
gyroxin was intravenously administrated at a dose 
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of 0.25 µg/g. We did not observe this symptom 
in the current study, even when inoculated 
intraperitoneally at 0.6 µg/g. However, some 
authors suggest that the barrel rotation syndrome 
is a special consequence of the intravenous 
administration of some viperid snake venoms 
(25, 29, 38).
Most neurotoxins show an effect on the 
peripheral nervous system, due to the fact 
that they do not cross the blood-brain barrier. 
However the action of venom and toxins on 
neuromuscular junction has not been elucidated. 
Snakes have developed the capacity to produce 
potent toxins able to inhibit the pre- and post-
synaptic neuromuscular transmission at specific 
sites (39). 
To verify the gyroxin effect upon the peripheral 
nervous system, the alterations in muscular 
twitches were analyzed. This evaluation was made 
from mouse phrenic-diaphragm preparation. 
The neuromuscular blockade was not observed 
suggesting that, at the concentrations utilized, 
gyroxin has no effect on the peripheral nervous 
system. Studies realized with crotoxin and 
gyroxin of Crotalus durissus terrificus venom 
demonstrated the presence of a pre-synaptic 
neurotoxic effect (29, 40). Gallacci et al. (41), 
showed a neuromuscular junction effect of 
crotoxin, but our results indicate that this effect 
was not produced by gyroxin. 
In contrast, several bothropic venoms have 
the capacity to block the in vitro neuromuscular 
transmission process, although the venoms of 
these snakes did not provoke clinical signs of 
neurotoxicity (42, 43). 
Finally, future studies to better understand the 
gyroxin action mechanism should be performed. 
The biological effects of this enzyme appear to 
constitute a potential candidate in bioprospecting 
for new drugs.
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